Scienture (SCNX) Stock Price, News & Analysis

Company Overview

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Key Stats

• Today's Range: $2.66 to $2.80
• 50-Day Range: $2.73 to $8.13
• 52-Week Range: $2.61 to $44.56
• Volume: 1,365 shs
• Average Volume: 10,252 shs
• Market Capitalization: $24.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SCNX Stock Analysis - Frequently Asked Questions

How have SCNX shares performed this year?

Scienture's stock was trading at $6.05 at the beginning of 2025. Since then, SCNX shares have decreased by 53.7% and is now trading at $2.80.
View the best growth stocks for 2025 here.

Who are Scienture's major shareholders?

Top institutional shareholders of Scienture include Millennium Management LLC (0.39%) and Geode Capital Management LLC (0.24%).

How do I buy shares of Scienture?

Shares of SCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Scienture own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Scienture investors own include Cogent Communications (CCOI), Cavco Industries (CVCO), Liberty Broadband (LBRDK), Liberty Global (LBTYB), PayPal (PYPL), Roku (ROKU) and Arch Capital Group (ACGL).

Company Calendar

• Today: 2/22/2025
• Next Earnings (Estimated): 4/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:SCNX
• CUSIP: N/A
• CIK: 1382574
• Web: www.trxadehealth.com
• Phone: (800) 261-0281
• Fax: 800-265-6932
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,840,000.00
• Net Margins: N/A
• Pretax Margin: -305.64%
• Return on Equity: -77.60%
• Return on Assets: -62.29%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.34
• Quick Ratio: 1.34

Sales & Book Value

• Annual Sales: $8.27 million
• Price / Sales: 2.96
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: 6.22

Miscellaneous

• Outstanding Shares: 8,750,000
• Free Float: 4,402,000
• Market Cap: $24.50 million
• Optionable: N/A
• Beta: 2.28